Nanomedicines (NMs) offer new solutions for cancer diagnosis and therapy. However, extension of progression-free interval and overall survival time achieved by Food and Drug Administration-approved NMs remain modest. To develop next generation NMs to achieve superior anticancer activities, it is cru...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!